Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
07/02/2020 18:48
Feb 7 (Reuters) - Aspire Health Sciences:
* ASPIRE HEALTH SCIENCES - ON JAN 28, 2020, INITIATED LEGAL
PROCEEDING AGAINST HEMOSTEMIX INC
* ASPIRE HEALTH SCIENCES - INITIATED LEGAL PROCEEDING
REGARDING
HEMOSTEMIX'S PURPORTED RESCISSION OF AMENDED LICENSE AGREEMENT
BETWEEN CO, HEMOSTEMIX
Source text for Eikon: urn:newsml:reuters.com:*:nCNWwFMnta
Further company coverage: HEM.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hemostemix
See all newsBrief: Hemostemix Announces Financing Update And Secured Convertible Debenture Financing Of Up To $2,000,000
Brief: Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial
Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
Brief: Hemostemix Announces Private Placement
Brief: Hemostemix Announces Corporate Update